The incidence of primary glomerulonephritis worldwide: a systematic review of the literature - PubMed (original) (raw)
Review
The incidence of primary glomerulonephritis worldwide: a systematic review of the literature
Anita McGrogan et al. Nephrol Dial Transplant. 2011 Feb.
Abstract
Background: Little is known about the worldwide variation in incidence of primary glomerulonephritis (GN). The objective of this review was to critically appraise studies of incidence published in 1980-2010 so that an overall view of trends of these diseases can be found. This would provide important information for determining changes in rates and understanding variations between countries.
Methods: All relevant papers found through searches of Medline, Embase and ScienceDirect were critically appraised and an assessment was made of the reliability of the reported incidence data.
Results: This review includes 40 studies of incidence of primary GN from Europe, North and South America, Canada, Australasia and the Middle East. Rates for the individual types of disease were found to be in adults, 0.2/100,000/year for membrano-proliferative GN, 0.2/100,000/year for mesangio-proliferative GN, 0.6/100,000/year for minimal change disease, 0.8/100,000/year for focal segmental glomerulosclerosis, 1.2/100,000/year for membranous nephropathy and 2.5/100,000/year for IgA nephropathy. Rates were lower in children at around 0.1/100,000/year with the exception of minimal change disease where incidence was reported to be 2.0/100,000/year in Caucasian children with higher rates in Arabian children (9.2/100,000/year) and Asian children (6.2-15.6/100,000/year).
Conclusions: This study found that incidence rates of primary GN vary between 0.2/100,000/year and 2.5/100,000/year. The incidence of IgA nephropathy is at least 2.5/100,000/year in adults; this disease can exist subclinically and is therefore only detected by chance in some patients. In addition, referral policies for diagnostic biopsy vary between countries. This will affect the incidence rates found.
Similar articles
- Epidemiology of biopsy-proven glomerulonephritis in Queensland adults.
Jegatheesan D, Nath K, Reyaldeen R, Sivasuthan G, John GT, Francis L, Rajmokan M, Ranganathan D. Jegatheesan D, et al. Nephrology (Carlton). 2016 Jan;21(1):28-34. doi: 10.1111/nep.12559. Nephrology (Carlton). 2016. PMID: 26154936 - The changing pattern of glomerulonephritis in Singapore over the past two decades.
Woo KT, Chiang GS, Pall A, Tan PH, Lau YK, Chin YM. Woo KT, et al. Clin Nephrol. 1999 Aug;52(2):96-102. Clin Nephrol. 1999. PMID: 10480220 - Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology.
Chiu HF, Chen HC, Lu KC, Shu KH; Taiwan Society of Nephrology. Chiu HF, et al. BMC Nephrol. 2018 Jan 10;19(1):6. doi: 10.1186/s12882-017-0810-4. BMC Nephrol. 2018. PMID: 29320993 Free PMC article. - Primary glomerulonephritis in mainland China: an overview.
Xie J, Chen N. Xie J, et al. Contrib Nephrol. 2013;181:1-11. doi: 10.1159/000348642. Epub 2013 May 8. Contrib Nephrol. 2013. PMID: 23689562 Review. - Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s.
Levy M, Chen N. Levy M, et al. Kidney Int Suppl. 1991 Dec;35:S24-33. Kidney Int Suppl. 1991. PMID: 1770708 Review.
Cited by
- Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
Tawengi M, Al-Dali Y, Tawengi A, Benter IF, Akhtar S. Tawengi M, et al. Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024. Front Pharmacol. 2024. PMID: 39234105 Free PMC article. Review. - A novel peptide ligand-coated nano-siRNA-lipoplex technology for kidney targeted gene therapy.
Liu X, Zhang J, Tang A, Xu L, Huang Y. Liu X, et al. Am J Transl Res. 2022 Oct 15;14(10):7362-7377. eCollection 2022. Am J Transl Res. 2022. PMID: 36398217 Free PMC article. - Identification of hub genes and their correlation with immune infiltrating cells in membranous nephropathy: an integrated bioinformatics analysis.
Han M, Wang Y, Huang X, Li P, Liang X, Wang R, Bao K. Han M, et al. Eur J Med Res. 2023 Nov 16;28(1):525. doi: 10.1186/s40001-023-01311-3. Eur J Med Res. 2023. PMID: 37974210 Free PMC article. - Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
Shankar M, Shetty A, N S M, C G S, A K, Tennankore K. Shankar M, et al. Sci Rep. 2023 Dec 4;13(1):21400. doi: 10.1038/s41598-023-47751-z. Sci Rep. 2023. PMID: 38049447 Free PMC article. - Targeting complement in IgA nephropathy.
Caravaca-Fontán F, Gutiérrez E, Sevillano ÁM, Praga M. Caravaca-Fontán F, et al. Clin Kidney J. 2023 Dec 4;16(Suppl 2):ii28-ii39. doi: 10.1093/ckj/sfad198. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38053977 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous